Company news

Astellas Pharma Inc. news in 2024

Astellas Pharma Inc.'s news releases, calls and decks from 2024, newest first.

Astellas VYLOY Approved by U.S. FDA for Treatment of Advanced Gastric and GEJ Cancer

October 21, 2024

Calls in 2024

Astellas Pharma (Tokyo:4503) Q2 2024 Earnings Call
Oct 30, 2024
Transcript
Astellas Pharma (Tokyo:4503) Q1 2024 Earnings Call
Aug 1, 2024
Transcript
Astellas Pharma (Tokyo:4503) Q4 2023 Earnings Call
Apr 25, 2024
Transcript
Astellas Pharma (Tokyo:4503) Q3 2023 Earnings Call
Feb 5, 2024
Transcript

Decks in 2024

Q2 FY2024 Earnings Presentation
Earnings · 49 slides · Oct 30, 2024
Q2 2024 Earnings Presentation
Earnings · 49 slides · Oct 30, 2024
Technical Presentation (September 2024)
Technical · 25 slides · Sep 27, 2024
Q1 FY2024 Earnings Presentation
Earnings · 38 slides · Aug 1, 2024
Q1 2024 Earnings Presentation
Earnings · 38 slides · Aug 1, 2024
FY2023 Earnings Presentation
Earnings · 49 slides · Apr 25, 2024
FY2023 Earnings Presentation
Earnings · 49 slides · Apr 25, 2024
Corporate Update (March 2024)
Corporate update · 25 slides · Mar 29, 2024
Corporate Update (March 2024)
Corporate update · 26 slides · Mar 29, 2024
ESG Presentation (February 2024)
Sustainability · 36 slides · Feb 21, 2024
ESG Presentation (February 2024)
Sustainability · 36 slides · Feb 21, 2024
Q3 FY2023 Earnings Presentation
Earnings · 41 slides · Feb 5, 2024
Q3 2023 Earnings Presentation
Earnings · 41 slides · Feb 5, 2024